shanghai runda medical technology (603108.SH) released its performance for the first three quarters, with a net income of 50.42 million yuan, a year-on-year decrease of 82.21%.

Zhitong Finance · Oct 29 18:08

Shanghai Runda Medical Technology (603108.SH) disclosed the third quarter report for 2024, with the company achieving a revenue of 61...

According to the Zhixun Finance APP, Shanghai Runda Medical Technology (603108.SH) disclosed the third quarter report for 2024. The company achieved a revenue of 6.176 billion yuan in the first three quarters, a 10.36% year-on-year decrease; net income attributable to the parent company was 50.42 million yuan, a decrease of 82.21% year-on-year; non-net profit was 32.54 million yuan, a decrease of 82.61% year-on-year; and basic earnings per share was 0.08 yuan.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

润达医疗(603108.SH)发布前三季度业绩，净利润5042万元，同比下降82.21%

shanghai runda medical technology (603108.SH) released its performance for the first three quarters, with a net income of 50.42 million yuan, a year-on-year decrease of 82.21%.

Risk Disclaimer

Statement